Trial Profile
A Randomized, Double-blind, Multi-center, Placebo Parallel-controlled, Standard Therapy Based Phase II Clinical Trial to Evaluate Efficacy of Recombinant Human Neuregulin-1 (NeucardinTM) for Injection
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 May 2013
Price :
$35
*
At a glance
- Drugs Recombinant human neuregulin 1-beta (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 24 May 2013 New trial record